General descriptionThe SHSY-5Y Tet-ON inducible α-synuclein neuroblastoma cell line serves as a model for both dopaminergic neuronal biology and α-synuclein pathology. SHSY-5Y cells may be induced upon treatment with retinoic acid to differentiate into neuronal-type cells, enabling studies of neuronal function and differentiation.4 SHSY-5Y cells secrete catecholamines and thus serve as a model for dopaminergic neurons. The SHSY-5Y TetON α-synuclein inducible cell line harbors an α-synuclein construct inducible by treatment with doxycycline, thus allowing controlled overexpression of α-synuclein before or after neuronal differentiation.5 The construct also includes a tet repressor, which prevents leaky expression in absence of inducer. This unique cell line is an excellent model for both the basic cellular physiology of Parkinson′s disease and therapeutic development.
ApplicationParkinson′s disease, the most common neurodegenerative movement disorder1, is caused by the progressive degeneration of dopaminergic neurons. A signature pathology of the brains of Parkinson′s patients is the buildup of misfolded aggregates of the protein α-synuclein.2 Aggregates of α-synuclein are also implicated in Lewy body dementia and Alzheimer′s disease.3 Although study of the complete pathogenesis of neurodegenerative diseases such as Parkinson′s requires animal models, cellular models that reflect distinct aspects of Parkinson′s pathology are of great value for understanding the multifaceted character of neurodegenerative diseases and useful for developing targeted treatments.The SHSY-5Y Tet-ON inducible α-synuclein neuroblastoma cell line serves as a model for both dopaminergic neuronal biology and α-synuclein pathology. SHSY-5Y cells may be induced upon treatment with retinoic acid to differentiate into neuronal-type cells, enabling studies of neuronal function and differentiation.4 SHSY-5Y cells secrete catecholamines and thus serve as a model for dopaminergic neurons. The SHSY-5Y TetON α-synuclein inducible cell line harbors an α-synuclein construct inducible by treatment with doxycycline, thus allowing controlled overexpression of α-synuclein before or after neuronal differentiation.5 The construct also includes a tet repressor, which prevents leaky expression in absence of inducer. This unique cell line is an excellent model for both the basic cellular physiology of Parkinson′s disease and therapeutic development.Source The SHSY-5Y Tet-ON Inducible -Synuclein cell line is stably transfected with a construct containing an alpha-synuclein cDNA cassette and CMV promoter under control of Tet-ON response element.5 The parental SHSY-5Y cell line was derived from a metastatic neuroblastoma of a 4-year-old female.6References1. Falkenburger BH, Saridaki T, Dinter E. J Neurochem 2016;139 (Suppl 1):121-130.2. Balestrino R, Schapira AHV. Eur J Neurol 2020; 27(1):27-42.3. Twohig D, Nielsen HM. Mol Neurodegener 2019; 14(1):23. 4. Agholme L et al. J Alzheimer′s Dis 2010; 20(4):1069-1082.5. Vasquez V, Mitra J, Perry G, Rao KS, Hegde ML. J Alzheimer′s Dis 2018; 66(2):453-460.6. Biedler JL, Helson L, Spengler BA. Cancer Res 1973; 33(11):2643-2652.
• Each vial contains ≥ 1X10⁶ viable cells.• SHSY-5Y Tet-ON Inducible -Synuclein Neuroblastoma cells are verified to be of human origin and negative for mouse, rat, Chinese hamster, Golden Syrian hamster, and non-human primate interspecies contamination, as assessed by a Contamination Clear panel by Charles River Animal Diagnostic Services • Cells tested negative for infectious diseases against a Human Essential CLEAR panel by Charles River Animal Diagnostic Services.• Cells tested negative for mycoplasma.
Features and BenefitsSHSY-5Y Tet-ON inducible α-synuclein neuroblastoma cell line serves as a model for both dopaminergic neuronal biology and α-synuclein pathology.
Preparation NoteThe cells should be stored in liquid nitrogen until use. The cells can be cultured for at least 10 passages after initial thawing without significantly affecting the cell marker expression and functionality.
Other NotesSubject to local law, this product is intended to be sold for internal in vitro research use only subject to terms and conditions found here: www.sigmaaldrich.com/restrictedcelluse. This product may not be: re-engineered or copied; used to make derivatives, modifications or functional equivalents; used to obtain patents or other IP claiming use of the product; used to develop, test, or manufacturer a commercial product; used as a component in a commercial product; resold or licensed; used in any clinical applications or trials; or used in humans. A license or limited commercial use agreement is required for use by any for-profit entity, use in services, and use in sponsored academic research. For information regarding any such use, please contact
[email protected].
DisclaimerRESEARCH USE ONLY. This product is regulated in France when intended to be used for scientific purposes, including for import and export activities (Article L 1211-1 paragraph 2 of the Public Health Code). The purchaser (i.e. enduser) is required to obtain an import authorization from the France Ministry of Research referred in the Article L1245-5-1 II. of Public Health Code. By ordering this product, you are confirming that you have obtained the proper import authorization.
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
